17 Healthcare Stocks Moving In Tuesday's Pre-Market Session

Gainers

• Eyegate Pharmaceuticals, Inc. EYEG stock surged 104.67% to $8.33 during Tuesday's pre-market session.

• Owens & Minor, Inc. OMI stock rose 17.48% to $9.88. The most recent rating by CFRA, on Mar 30, is at Buy, with a price target of $9.

• Tiziana Life Sciences, Inc. TLSA shares increased by 12.90% to $2.10.

• InflaRx, Inc. IFRX shares increased by 10.48% to $3.90.

• Adamis Pharmaceuticals, Inc. ADMP shares moved upwards by 8.19% to $0.40.

• Tilray, Inc. TLRY stock rose 4.99% to $6.94. The most recent rating by Cantor Fitzgerald, on Mar 16, is at Neutral, with a price target of $5.

• Teva Pharmaceutical Indus, Inc. TEVA shares surged 3.87% to $8.85. The most recent rating by B of A Securities, on Mar 23, is at Underperform, with a price target of $7.

Losers

Pre-IPO Offer: Get A Piece Of A Nearly $5T Global Opportunity By Joining BOXABL As An Early Shareholder At Just $0.80/Share

• Massive Demand & Disruptive Potential – Boxabl has received interest for over 190,000 homes, positioning itself as a major disruptor in the housing market.
• Revolutionary Manufacturing Approach – Inspired by Henry Ford’s assembly line, Boxabl’s foldable tiny homes are designed for high-efficiency production, making homeownership more accessible.
• Affordable Investment Opportunity – With homes priced at $60,000, Boxabl is raising $1 billion to scale production, offering investors a chance to own a stake in its growth.

Share Price: $0.80

Min. Investment: $1,000

Valuation: $3.5B

Click Here To Invest For Just $0.80/Share ($1000 Min)

• Amarin Corp, Inc. AMRN stock plummeted 70.99% to $3.94 during Tuesday's pre-market session. The most recent rating by Goldman Sachs, on Mar 31, is at Neutral, with a price target of $4.

• Titan Medical, Inc. TMDI stock declined 30.23% to $0.24.

• Second Sight Medical, Inc. EYES shares declined 21.93% to $0.89.

• Plus Therapeutics, Inc. PSTV stock decreased by 13.22% to $1.97.

• electroCore, Inc. ECOR stock plummeted 9.92% to $1.09. The most recent rating by H.C. Wainwright, on Mar 24, is at Buy, with a price target of $2.

• CHF Solutions, Inc. CHFS stock fell 6.86% to $0.41.

• Cronos Group, Inc. CRON shares decreased by 4.26% to $6.07. According to the most recent rating by Canaccord Genuity, on Mar 31, the current rating is at Sell.

• T2 Biosystems, Inc. TTOO stock decreased by 3.33% to $0.58.

• Grifols, Inc. GRFS stock decreased by 3.25% to $19.93.

• Correvio Pharma, Inc. CORV stock declined 3.25% to $0.36.